Page A1 | The Philadelphia Tribune e-Edition
View the The Philadelphia Tribune for Sunday, September 3, 2023
Source: phillytrib.com
Page 5 - Focal One News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Focal One. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Focal One Today - Breaking & Trending Today
EDAP TMS S.A. (NASDAQ:EDAP) Q2 2023 Earnings Call Transcript
EDAP TMS S.A. (NASDAQ:EDAP) Q2 2023 Earnings Call Transcript August 24, 2023 EDAP TMS S.A. beats earnings expectations. Reported EPS is $0.13, expectations were $-0.03. Operator: Greetings, and welcome to the EDAP TMS Second Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn […]
Source: yahoo.com
EDAP Announces Second Quarter 2023 Financial Results
- Record second quarter and first half revenues of EUR 14.3 million and EUR 29.1 million , respectively - - Total HIFU Q2 2023 year-over-year revenue growth of 63.6% - - Strong Q2 2023...
Source: marketscreener.com
10 ASC 'firsts' in the last 60 days
Explore 10 ASC firsts from the last 60 days, including robotic sacrocolpopexy, AI-assisted hip replacements, and a world's first "clean cube" operating room
Source: beckersasc.com
EDAP Announces Reimbursement Approval in Switzerland for the Use of High-Intensity Focused Ultrasound (HIFU) in the Treatment of Prostate Cancer
LYON, France, July 26, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it has received reimbursement approval in Switzerland for the use of High-Intensity Focused Ultrasound (HIFU) in the treatment of prostate cancer. This reimbursement took effect on July 1, 2023. "Receipt of appropriate reimbursement from the Swiss healthcare authorities is another acknowledgment of the growing, worldwide acceptance of HIFU as an eff
Source: yahoo.com